MedPath

Evaluating and Comparing the levels of MBL in normal and periodontitis affected patients.

Not Applicable
Registration Number
CTRI/2021/10/037522
Lead Sponsor
TPCTs Terna Dental College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Subjects between the age group of 18 â?? 60 years.

2. Subjects who have not received periodontal therapy, in the previous

six months.

3.Subjects who readily give informed consent for the study.

4. Systemically healthy patients.

Exclusion Criteria

1.Consumption of tobacco in any form and alcoholics.

2.Pregnant and lactating females.

3. Subjects who have received anti-inflammatory, antibiotic and

steroid drugs in previous three months.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.To determine the levels of MBL in serum of periodontally healthy patients. <br/ ><br>2.To determine the levels of MBL in serum of chronic periodontitis patients. <br/ ><br>3. To compare levels of MBL in serum of periodontally healthy and chronic <br/ ><br>periodontitis patients. <br/ ><br>4.To correlate the effect of scaling and root planing on the levels of MBL in serum <br/ ><br>of chronic periodontitis patients. <br/ ><br>Timepoint: Baseline <br/ ><br>4 weeks after scaling and root planing
Secondary Outcome Measures
NameTimeMethod
To evaluate improvement in plaque index <br/ ><br>,gingival index,pocket probing depth and clinical <br/ ><br>attachment level in patients with chronic <br/ ><br>periodontitis 4 weeks after scaling and root <br/ ><br>planing.Timepoint: plaque index ,gingival index,pocket probing <br/ ><br>depth and clinical attachment level in patients <br/ ><br>with chronic periodontitis will be taken at <br/ ><br>baseline and then 4 weeks after scaling and root <br/ ><br>planing.
© Copyright 2025. All Rights Reserved by MedPath